ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Breaks Ground For Clinical Center

November 14, 1997

No Cancer Letter For Next Two Weeks

August 30, 1991

Columbia Univ. Places cDNA Libraries In Public Domain

April 28, 1995

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says

June 19, 1998

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007